[Search for an Optimal Formula for Calculation of the Corrected QT Interval in Children Based on Data of

M A Shkolnikova1, O Y Podshivalova1, L A Kalinin1

  • 11Moscow Research Institute of Pediatrics and Pediatric Surgery N.I. Pirogov Russian National Research State Medical University, Moscow, Russia; 2Centre for Demographic Research at theNew Economic School, Moscow, Russia.

Kardiologiia
|March 16, 2017
PubMed

Insights

This study recommends a modified Bazett formula for corrected QT (QTc) duration in children. This new formula better accounts for heart rate (HR) variations in pediatric populations.

Area of Science:

  • Pediatric Cardiology
  • Biomedical Engineering
  • Clinical Electrophysiology

Background:

  • Accurate QT duration measurement is crucial for assessing pediatric cardiac health.
  • Existing QT correction formulas may not adequately account for heart rate variability in children.
  • Establishing age-specific norms for QT duration is essential for accurate interpretation.

Purpose of the Study:

  • To compare various corrected QT (QTc) formulas in children.
  • To establish age-specific QT duration norms.
  • To evaluate the association between QT duration and heart rate (HR) in pediatric populations.

Main Methods:

  • Analysis of QT intervals and heart rate (RR intervals) in 5909 children aged 0-18 years.
  • Comparison of Bazett, Fridericia, Framingham, Hodges, and a novel modified Bazett formula.
  • Assessment of formula performance in eliminating heart rate influence on QT duration.

Main Results:

  • No single formula completely eliminated the QT-RR interval correlation.
  • The Bazett formula offered the greatest reduction in HR influence among existing formulas.
  • The novel modified Bazett formula demonstrated an even lower QT-RR interval correlation.

Conclusions:

  • A modified Bazett formula is recommended for improved pediatric QT correction.
  • This modified formula offers enhanced accuracy by minimizing heart rate influence.
  • Implementation in pediatric practice can lead to more reliable cardiac assessments.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
615
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
305
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
236
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
374
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285